Report Detail
Global (United States, European Union and China) Pet Cancer Therapeutics Market Research Report 2019-2025
- RnM3650457 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Pet cancer therapeutics are the novel drug molecules that exhibit high potential to reduce the effects of cancer, giving access to comprehensive cancer care with minimum side effects. Cancer therapies aims to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatment program such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer.
The ongoing research activities undertaken by the scientists for the development of novel formulations and therapies is expected to accelerate the market growth.
In 2019, the market size of Pet Cancer Therapeutics is 180 million US$ and it will reach 330 million US$ in 2025, growing at a CAGR of 7.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pet Cancer Therapeutics.
This report studies the global market size of Pet Cancer Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pet Cancer Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
Market Segment by Product Type
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Market Segment by Application
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pet Cancer Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pet Cancer Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pet Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pet Cancer Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Chemotherapy
- 1.3.3 Targeted Therapy
- 1.3.4 Combination Therapy
- 1.3.5 Immunotherapy
- 1.4 Market Segment by Application
- 1.4.1 Global Pet Cancer Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Lymphoma
- 1.4.3 Mast Cell Cancer
- 1.4.4 Melanoma
- 1.4.5 Mammary
- 1.4.6 Squamous Cell Cancer
- 1.4.7 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pet Cancer Therapeutics Market Size
- 2.1.1 Global Pet Cancer Therapeutics Revenue 2014-2025
- 2.1.2 Global Pet Cancer Therapeutics Sales 2014-2025
- 2.2 Pet Cancer Therapeutics Growth Rate by Regions
- 2.2.1 Global Pet Cancer Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Pet Cancer Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Pet Cancer Therapeutics Sales by Manufacturers
- 3.1.1 Pet Cancer Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Pet Cancer Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Pet Cancer Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Pet Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pet Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Pet Cancer Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Pet Cancer Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pet Cancer Therapeutics Market
- 3.6 Key Manufacturers Pet Cancer Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Chemotherapy Sales and Revenue (2014-2019)
- 4.1.2 Targeted Therapy Sales and Revenue (2014-2019)
- 4.1.3 Combination Therapy Sales and Revenue (2014-2019)
- 4.1.4 Immunotherapy Sales and Revenue (2014-2019)
- 4.2 Global Pet Cancer Therapeutics Sales Market Share by Type
- 4.3 Global Pet Cancer Therapeutics Revenue Market Share by Type
- 4.4 Pet Cancer Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pet Cancer Therapeutics Sales by Application
6 United States
- 6.1 United States Pet Cancer Therapeutics Breakdown Data by Company
- 6.2 United States Pet Cancer Therapeutics Breakdown Data by Type
- 6.3 United States Pet Cancer Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Pet Cancer Therapeutics Breakdown Data by Company
- 7.2 European Union Pet Cancer Therapeutics Breakdown Data by Type
- 7.3 European Union Pet Cancer Therapeutics Breakdown Data by Application
8 China
- 8.1 China Pet Cancer Therapeutics Breakdown Data by Company
- 8.2 China Pet Cancer Therapeutics Breakdown Data by Type
- 8.3 China Pet Cancer Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Pet Cancer Therapeutics Breakdown Data by Company
- 9.2 Rest of World Pet Cancer Therapeutics Breakdown Data by Type
- 9.3 Rest of World Pet Cancer Therapeutics Breakdown Data by Application
- 9.4 Rest of World Pet Cancer Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Pet Cancer Therapeutics Sales by Countries
- 9.4.2 Rest of World Pet Cancer Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Aratana Therapeutics, Inc
- 10.1.1 Aratana Therapeutics, Inc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.1.4 Pet Cancer Therapeutics Product Introduction
- 10.1.5 Aratana Therapeutics, Inc Recent Development
- 10.2 AB Science
- 10.2.1 AB Science Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.2.4 Pet Cancer Therapeutics Product Introduction
- 10.2.5 AB Science Recent Development
- 10.3 Boehringer Ingelheim International GmbH
- 10.3.1 Boehringer Ingelheim International GmbH Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.3.4 Pet Cancer Therapeutics Product Introduction
- 10.3.5 Boehringer Ingelheim International GmbH Recent Development
- 10.4 Zenoaq
- 10.4.1 Zenoaq Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.4.4 Pet Cancer Therapeutics Product Introduction
- 10.4.5 Zenoaq Recent Development
- 10.5 Morphogenesis, Inc
- 10.5.1 Morphogenesis, Inc Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.5.4 Pet Cancer Therapeutics Product Introduction
- 10.5.5 Morphogenesis, Inc Recent Development
- 10.6 VetDC, Inc
- 10.6.1 VetDC, Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.6.4 Pet Cancer Therapeutics Product Introduction
- 10.6.5 VetDC, Inc Recent Development
- 10.7 Karyopharm Therapeutics, Inc
- 10.7.1 Karyopharm Therapeutics, Inc Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.7.4 Pet Cancer Therapeutics Product Introduction
- 10.7.5 Karyopharm Therapeutics, Inc Recent Development
- 10.8 Rhizen Pharmaceutical SA
- 10.8.1 Rhizen Pharmaceutical SA Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.8.4 Pet Cancer Therapeutics Product Introduction
- 10.8.5 Rhizen Pharmaceutical SA Recent Development
- 10.9 Regeneus Ltd.
- 10.9.1 Regeneus Ltd. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.9.4 Pet Cancer Therapeutics Product Introduction
- 10.9.5 Regeneus Ltd. Recent Development
- 10.10 Oasmia Pharmaceuticals AB
- 10.10.1 Oasmia Pharmaceuticals AB Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Pet Cancer Therapeutics
- 10.10.4 Pet Cancer Therapeutics Product Introduction
- 10.10.5 Oasmia Pharmaceuticals AB Recent Development
- 10.11 Zoetis
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pet Cancer Therapeutics Sales Channels
- 11.2.2 Pet Cancer Therapeutics Distributors
- 11.3 Pet Cancer Therapeutics Customers
12 Market Forecast
- 12.1 Global Pet Cancer Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Pet Cancer Therapeutics Sales Forecast by Type
- 12.3 Global Pet Cancer Therapeutics Sales Forecast by Application
- 12.4 Pet Cancer Therapeutics Forecast by Regions
- 12.4.1 Global Pet Cancer Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Pet Cancer Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pet Cancer Therapeutics. Industry analysis & Market Report on Pet Cancer Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Pet Cancer Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pet Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
